| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |